Minnesota House Bill HF1093

Minnesota 2025-2026 Regular Session

• Introduced: 2/17/25
• Refer: 2/17/25

Caption

Commissioner of human services directed to establish a prescription drug purchasing program, program authority and eligibility requirements specified, and recommendations required.

Impact

If enacted, HF1093 would impact existing state healthcare statutes by creating a new system for purchasing and administering prescription drugs through state coordination. The bill requires federal approval for implementation and mandates the commissioner to pursue the necessary regulations at the federal level. The anticipated effect is a centralized approach to drug purchasing that could lead to potential savings for the state and improved access for participants in public health assistance programs.

Summary

House File 1093 proposes the establishment of a prescription drug purchasing program managed by the commissioner of human services. This program aims to provide prescription drugs to participants in the medical assistance and MinnesotaCare programs under fee-for-service and managed care systems. The bill outlines the commissioner’s responsibilities, including obtaining drugs at the lowest possible prices and maintaining a list of the most effective drugs available at reasonable costs. This initiative seeks to improve health outcomes by offering comprehensive prescription benefit services.

Contention

There may be points of contention regarding the bill primarily around its implementation and funding. While the intention is to lower drug costs for participants, stakeholders may voice concerns about the efficacy of negotiations with pharmaceutical companies, the adequacy of the formulary, and the care standards maintained by pharmacies under the program. Additionally, the bill proposes to develop recommendations for expanding the program to health plan company enrollees, which may prompt discussions over disparity in coverage and access among different groups within the state.